Company Filing History:
Years Active: 2013-2014
Title: Yakov Rotshteyn: Innovator in Opioid Receptor Antagonists
Introduction
Yakov Rotshteyn is a notable inventor based in Monroe, NY (US), recognized for his contributions to the field of pharmaceutical innovations. He holds 2 patents that focus on peripheral opioid receptor antagonists, which are crucial in addressing the side effects associated with opioid administration.
Latest Patents
His latest patents include significant advancements in the development of compounds that serve as peripheral mu opioid receptor antagonists. The inventions provide a compound of formula I, wherein R, R, R, and X are defined and described in detail. These compounds are designed to be useful in treating the adverse effects of opioid use, showcasing Rotshteyn's commitment to improving patient care.
Career Highlights
Throughout his career, Yakov Rotshteyn has worked with prominent companies in the pharmaceutical industry, including Progenics Pharmaceuticals, Inc. and Wyeth. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the field of opioid receptor antagonism.
Collaborations
Yakov has collaborated with esteemed colleagues such as Alfred A Avey and Appavu Chandrasekaren, further enhancing the impact of his work in the pharmaceutical sector.
Conclusion
Yakov Rotshteyn's innovative work in the development of peripheral opioid receptor antagonists marks him as a significant figure in the pharmaceutical industry. His patents and collaborations reflect his dedication to advancing medical science and improving treatment options for patients.